13F-HR filed by HealthCor Management, L.P.
HealthCor Management, L.P. filed this 13F-HR for the quarter ended 2021-06-30, filed 2021-08-16, with 72 holding rows worth $2,501,753,000.
- Accession
- 0001343781-21-000006
- Filer
- CIK 1343781
- Filed
- 2021-08-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2021
A holdings report, 72 entries on the cover page, a total value of $2,501,753,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,501,753,000 with VALUE read as thousands by filing date, 13F file number 028-11790. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ZIMMER BIOMET HOLDINGS INC COM | 98956P102 | Stock | 764,330 | $122,920,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 339,300 | $117,489,000 | thousands by filing date | |
| HORIZON THERAPEUTICS PLC | G46188101 | SHS | 1,235,048 | $115,650,000 | thousands by filing date | |
| PETCO HEALTH AND WELLNESS CO | 71601V105 | COM | 4,944,450 | $110,805,000 | thousands by filing date | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 190,380 | $106,335,000 | thousands by filing date | |
| HUMANA INC COM | 444859102 | Stock | 239,030 | $105,823,000 | thousands by filing date | |
| CVS Health Corporation | 126650100 | COM | 1,267,330 | $105,746,000 | thousands by filing date | |
| Danaher Corporation | 235851102 | COM | 384,920 | $103,297,000 | thousands by filing date | |
| Bristol-Myers Squibb Company | 110122108 | COM | 1,474,370 | $98,517,000 | thousands by filing date | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 182,970 | $92,303,000 | thousands by filing date | |
| NATERA INC COM | 632307104 | Stock | 789,658 | $89,650,000 | thousands by filing date | |
| ENCOMPASS HEALTH CORP COM | 29261A100 | Stock | 1,055,316 | $82,346,000 | thousands by filing date | |
| Medtronic Plc | G5960L103 | COM | 600,720 | $74,567,000 | thousands by filing date | |
| ALIGN TECHNOLOGY INC COM | 016255101 | Stock | 118,780 | $72,575,000 | thousands by filing date | |
| Stryker Corporation | 863667101 | COM | 273,190 | $70,956,000 | thousands by filing date | |
| NEVRO CORP | 64157F103 | COM | 376,330 | $62,392,000 | thousands by filing date | |
| MARAVAI LIFESCIENCES HLDGS A | 56600D107 | COMMON STOCK | 1,255,597 | $52,396,000 | thousands by filing date | |
| Boston Scientific Corporation | 101137107 | COM | 1,210,570 | $51,764,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 3,248,100 | $51,352,000 | thousands by filing date | |
| ENVISTA HOLDINGS CORPORATION | 29415F104 | COM | 1,165,860 | $50,377,000 | thousands by filing date | |
| UNIVERSAL HLTH SVCS INC CL B | 913903100 | Stock | 325,577 | $47,674,000 | thousands by filing date | |
| ZOETIS INC CL A | 98978V103 | Stock | 229,170 | $42,708,000 | thousands by filing date | |
| VEEVA SYS INC CL A COM | 922475108 | Stock | 136,080 | $42,314,000 | thousands by filing date | |
| Amgen Inc. | 031162100 | COM | 158,280 | $38,581,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 389,980 | $37,953,000 | thousands by filing date | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 187,000 | $37,705,000 | thousands by filing date | call |
| WELLTOWER INC COM | 95040Q104 | REIT | 434,590 | $36,114,000 | thousands by filing date | |
| HCA Healthcare Inc | 40412C101 | COM | 169,710 | $35,086,000 | thousands by filing date | |
| MCKESSON CORP COM | 58155Q103 | Stock | 160,760 | $30,744,000 | thousands by filing date | |
| CENCORA INC COM | 03073E105 | Stock | 264,340 | $30,264,000 | thousands by filing date | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 1,751,342 | $30,071,000 | thousands by filing date | |
| HALOZYME THERAPEUTICS INC COM | 40637H109 | Stock | 649,052 | $29,473,000 | thousands by filing date | |
| VENTAS INC COM | 92276F100 | REIT | 489,640 | $27,958,000 | thousands by filing date | |
| TENET HEALTHCARE CORP COM NEW | 88033G407 | Stock | 376,180 | $25,200,000 | thousands by filing date | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 117,960 | $23,784,000 | thousands by filing date | |
| INCYTE CORP COM | 45337C102 | Stock | 267,000 | $22,463,000 | thousands by filing date | call |
| DEXCOM INC COM | 252131107 | Stock | 50,890 | $21,730,000 | thousands by filing date | |
| LONGVIEW ACQUISITION CORP II | 54319Q105 | COM CL A | 2,135,900 | $20,932,000 | thousands by filing date | |
| AFFIMED N V | N01045108 | COM | 2,422,964 | $20,595,000 | thousands by filing date | |
| IDEXX LABS INC COM | 45168D104 | Stock | 29,900 | $18,883,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 749,310 | $14,829,000 | thousands by filing date | |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 386,190 | $14,138,000 | thousands by filing date | |
| RESEARCH ALLIANCE CORP II | 760873109 | CMN | 1,324,800 | $13,433,000 | thousands by filing date | |
| ARYA SCIENCES ACQU CORP IV | G31659108 | COM | 1,238,881 | $13,281,000 | thousands by filing date | |
| LIVANOVA PLC | G5509L101 | SHS | 125,000 | $10,514,000 | thousands by filing date | |
| MEDICUS SCIENCES ACQUISITION | G5960S108 | CL A SHS | 744,000 | $7,180,000 | thousands by filing date | |
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 522,712 | $6,727,000 | thousands by filing date | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 200,000 | $6,358,000 | thousands by filing date | |
| GH RESEARCH PLC ORDINARY SHARES | G3855L106 | Stock | 250,000 | $5,433,000 | thousands by filing date | |
| IKENA ONCOLOGY INC | 45175G108 | COM | 377,551 | $5,301,000 | thousands by filing date | |
| ORION ACQUISITION CORP | 68626A108 | CMN | 547,598 | $5,290,000 | thousands by filing date | |
| CM LIFE SCIENCES III INC | 125841106 | CLASS A COM | 500,000 | $5,160,000 | thousands by filing date | |
| NOVAVAX INC | 670002401 | COM NEW | 23,500 | $4,989,000 | thousands by filing date | put |
| ABG ACQUISITION CORP I | G00496102 | CL A SHS | 329,400 | $3,228,000 | thousands by filing date | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 41,080 | $2,830,000 | thousands by filing date | |
| OMEGA ALPHA SPAC | G6749V107 | CL A | 271,038 | $2,697,000 | thousands by filing date | |
| SARISSA CAPITAL ACQUISITN CO | G7823W128 | UNIT 10/23/2027 | 262,150 | $2,687,000 | thousands by filing date | |
| CYTEIR THERAPEUTICS INC | 23284P103 | COMMON | 120,000 | $2,568,000 | thousands by filing date | |
| EUCRATES BIOMEDICAL ACQU COR | G3141W114 | UNIT 10/23/2027 | 234,180 | $2,389,000 | thousands by filing date | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 103,717 | $2,362,000 | thousands by filing date | |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 100,000 | $2,270,000 | thousands by filing date | |
| MERUS N V | N5749R100 | COM | 96,438 | $2,032,000 | thousands by filing date | |
| JOUNCE THERAPEUTICS INC | 481116101 | COM | 268,295 | $1,824,000 | thousands by filing date | |
| JIYA ACQUISITION CORP | 47760M102 | CMN | 140,680 | $1,398,000 | thousands by filing date | |
| ATAIBECKLEY INC | N0731H103 | Equity | 75,000 | $1,388,000 | thousands by filing date | |
| ELEVATION ONCOLOGY INC COM | 28623U101 | Stock | 100,000 | $1,357,000 | thousands by filing date | |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 11,000 | $1,068,000 | thousands by filing date | |
| LONGVIEW ACQUISITION CORP II | 54319Q113 | *W EXP 99/99/999 | 427,178 | $585,000 | thousands by filing date | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 149,170 | $473,000 | thousands by filing date | |
| CM LIFE SCIENCES III INC | 125841114 | *W EXP 04/30/202 | 99,998 | $258,000 | thousands by filing date | |
| ORION ACQUISITION CORP | 68626A116 | WTS | 137,305 | $131,000 | thousands by filing date | |
| MEDICUS SCIENCES ACQUISITION | G5960S124 | *W EXP 02/12/202 | 82,663 | $83,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001343781-21-000006 | this filing | 2021-08-16 | acceptance time not in the bulk data set |